Scribd Logo
Upload

Welcome to Scribd!

  • 24 views

    Ceftriax Cefotax Due-2

    Uploaded by

    Regita Ayu
    This document summarizes a 1995 study that evaluated the use of cefotaxime and ceftriaxone in pediatrics to consider their cost-effectiveness. The study found that from January to June, 25,125 days of therapy were provided with cefotaxime or ceftriaxone, averaging 62.3% daily use. From July to December, the days of therapy decreased to 6,035, averaging 25.0% daily use. The most common reason for prescribing the drugs was empiric treatment of suspected sepsis.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Ceftriax Cefotax Due-2

    Uploaded by

    Regita Ayu
    24 views4 pages
    This document summarizes a 1995 study that evaluated the use of cefotaxime and ceftriaxone in pediatrics to consider their cost-effectiveness. The study found that from January to June, 25,125 days of therapy were provided with cefotaxime or ceftriaxone, averaging 62.3% daily use. From July to December, the days of therapy decreased to 6,035, averaging 25.0% daily use. The most common reason for prescribing the drugs was empiric treatment of suspected sepsis.

    Original Description:

    CEFO

    Original Title

    CEFTRIAX_CEFOTAX_DUE-2

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    This document summarizes a 1995 study that evaluated the use of cefotaxime and ceftriaxone in pediatrics to consider their cost-effectiveness. The study found that from January to June, 25,125 days of therapy were provided with cefotaxime or ceftriaxone, averaging 62.3% daily use. From July to December, the days of therapy decreased to 6,035, averaging 25.0% daily use. The most common reason for prescribing the drugs was empiric treatment of suspected sepsis.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    24 views4 pages

    Ceftriax Cefotax Due-2

    Uploaded by

    Regita Ayu
    This document summarizes a 1995 study that evaluated the use of cefotaxime and ceftriaxone in pediatrics to consider their cost-effectiveness. The study found that from January to June, 25,125 days of therapy were provided with cefotaxime or ceftriaxone, averaging 62.3% daily use. From July to December, the days of therapy decreased to 6,035, averaging 25.0% daily use. The most common reason for prescribing the drugs was empiric treatment of suspected sepsis.

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 4

    See discussions, stats, and author profiles for this publication at: https://www.researchgate.

    net/publication/15612182

    Cefotaxime and ceftriaxone use evaluation in pediatrics. Considerations of


    cost effectiveness

    Article  in  Diagnostic Microbiology and Infectious Disease · May 1995


    DOI: 10.1016/0732-8893(95)00081-K · Source: PubMed

    CITATIONS READS

    9 597

    2 authors, including:

    Carlton K Lee
    Johns Hopkins Medicine
    43 PUBLICATIONS   1,178 CITATIONS   

    SEE PROFILE

    All content following this page was uploaded by Carlton K Lee on 26 September 2017.

    The user has requested enhancement of the downloaded file.


    DIACN MICROBIOL INFECT ms %%5;22:231-233
    @ 1995 Elsevier ?kience Inc.
    655 Avenue of the Americas, New York, NY lOOlO
    axone were i

    ns was ini~ate

    onth

    January 66.4
    February 65.0
    March 75.8
    April 55.8
    May 3342 55.2
    and 100% physician accep- June 3127 55.8
    WY 1257 25.7
    AUgWil 919 24.0
    September 386 14.6
    October 2037 46.9”
    669 18.9
    December 769 25.5

    January-June 25,125 62.3


    e reasons for drug use at July-December 6035 25.0b
    the baseline assessment are summarized in Table 1.
    50% of this was attributed to two older patients who received
    The most common reason was empiric treatment of high ceftriaxone doses far long durations.
    Suspected sepsis (51.3%). bpracticefactor = 0.741 (l-0.259).
    xone versus

    View publication stats

    You might also like